2 results match your criteria: "China. Electronic address: fengy@sj-hospital.org.[Affiliation]"
The role of FKBP51 in the prognosis of ulcerative colitis-associated colorectal cancer.
Adv Med Sci
March 2021
Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address:
Purpose: Ulcerative colitis (UC) carries a high risk of developing colorectal cancer (CRC). FK506-binding protein 51 (FKBP51) is a key regulator of glucocorticoid resistance and inflammatory tumor microenvironment. This study aimed to investigate the role of FKBP51 in UC-CRC prognosis.
View Article and Find Full Text PDFLow-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.
Int Immunopharmacol
June 2020
Department of General Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning Province, China. Electronic address:
The incidence of colorectal cancer (CRC) is increasing annually worldwide. However, traditional chemotherapy has obvious side effects. Low-dose naltrexone (LDN) has been reported to delay tumor progression, but the mechanism remains unclear.
View Article and Find Full Text PDF